Innovative Molecule Simultaneously Targets Tumors and Silences Two 'Undruggable' Cancer Genes
UNC researchers have developed a novel 'two-in-one' molecule using inverted RNAi technology that can simultaneously silence two challenging cancer genes, KRAS and MYC, and deliver drugs to tumors, offering promising new treatment avenues for difficult cancers.